Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bellicum Pharma Comm (BLCM)

Bellicum Pharma Comm (BLCM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,629
  • Shares Outstanding, K 8,398
  • Annual Sales, $ 500 K
  • Annual Income, $ -7,720 K
  • 60-Month Beta 1.75
  • Price/Sales 56.94
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BLCM with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -2.47
  • Growth Rate Est. (year over year) +40,545.34%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.57 +28.02%
on 05/19/21
3.50 -6.00%
on 06/09/21
+0.25 (+8.22%)
since 05/11/21
3-Month
2.57 +28.02%
on 05/19/21
4.70 -30.00%
on 03/15/21
-1.07 (-24.54%)
since 03/11/21
52-Week
2.57 +28.02%
on 05/19/21
9.15 -64.04%
on 06/19/20
-3.91 (-54.31%)
since 06/11/20

Most Recent Stories

More News
Bellicum Reports First Quarter 2021 Financial Results and Provides Operational Update

Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial results for the first quarter 2021 and provided...

BLCM : 3.29 (-2.95%)
Bellicum Reports Fourth Quarter 2020 Financial Results and Provides Operational Update

Enrolled first patient in Phase 1/2 clinical trial for BPX-603 in solid tumors that express HER2

BLCM : 3.29 (-2.95%)
Bellicum Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 30, 2021 / Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 30, 2021...

BLCM : 3.29 (-2.95%)
Bellicum to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced it will report financial results for the fourth quarter and...

BLCM : 3.29 (-2.95%)
Bellicum Announces First Reported Use of CaspaCIDe(R) Safety Switch to Mitigate CAR-T Cell Toxicity

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced the publication of a case report using the company's CaspaCIDe...

BLCM : 3.29 (-2.95%)
Talaris Therapeutics Appoints Four Vice Presidents in Areas of Strategic Importance

Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing an innovative method of allogeneic hematopoietic stem cell transplantation with the potential to transform the standard...

BLCM : 3.29 (-2.95%)
Bellicum Pharmac Up 52.8% Since SmarTrend Uptrend Call (BLCM)

SmarTrend identified an Uptrend for Bellicum Pharmac (NASDAQ:BLCM) on December 1st, 2020 at $3.71. In approximately 3 months, Bellicum Pharmac has returned 52.83% as of today's recent price of $5.67.

BLCM : 3.29 (-2.95%)
Uptrend Call Working As Bellicum Pharmac Stock Rises 58.5% (BLCM)

SmarTrend identified an Uptrend for Bellicum Pharmac (NASDAQ:BLCM) on December 1st, 2020 at $3.71. In approximately 2 months, Bellicum Pharmac has returned 58.49% as of today's recent price of $5.88.

BLCM : 3.29 (-2.95%)
Ponce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin

, /PRNewswire/ -- Ponce Therapeutics, Inc. ("Ponce"), a company leveraging the growing scientific knowledge surrounding the aging process to develop anti-aging technologies, has now become operational...

BLCM : 3.29 (-2.95%)
Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that the U.S. Food and Drug Administration (FDA) has lifted...

BLCM : 3.29 (-2.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. The Company's lead clinical product...

See More

Key Turning Points

3rd Resistance Point 3.57
2nd Resistance Point 3.48
1st Resistance Point 3.39
Last Price 3.29
1st Support Level 3.21
2nd Support Level 3.12
3rd Support Level 3.03

See More

52-Week High 9.15
Fibonacci 61.8% 6.64
Fibonacci 50% 5.86
Fibonacci 38.2% 5.08
Last Price 3.29
52-Week Low 2.57

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar